Henry Meds Review 2026: Trustpilot 4.5 vs BBB F-Rating

Advertiser Disclosure: BestMedsHub may earn a commission when readers sign up with telehealth providers linked on this page. Editorial recommendations are independent. This article is informational only and is not a substitute for personalized care from a licensed clinician.

Last updated: May 20, 2026 · Medically reviewed by Dr. Marcus Tan, MD · ~9 min read

In May 2026, Henry Meds prices compounded semaglutide at $197 to $397 per month by dose, with oral semaglutide $99-$149 and compounded tirzepatide from $199 — all bundled with visits and shipping. The advertised “starting at $179” applies only to liraglutide or 12-month prepay. Trust signals are mixed: Trustpilot 4.5 across 12,000 reviews (flagged for suspected inauthenticity), BBB F-rating, and an active Eli Lilly lawsuit filed April 2025.

Henry Meds at a glance: meds, prices, what’s actually included

Henry Meds is a direct-to-consumer telehealth brand based in Boise, Idaho, offering bundled GLP-1 programs that wrap clinician visits, prescriptions, lab review, and shipping into a single monthly fee. Unlike Sequence/WeightWatchers Clinic, which dropped compounded GLP-1 in May 2025, Henry Meds continues to lean on 503A compounded semaglutide and tirzepatide as its core product. That decision sits at the center of every other story in this review — pricing, trust signals, regulatory exposure, and the Eli Lilly lawsuit.

The model is simple: one monthly price, no separate membership fee. That’s a real differentiator versus stacked-fee competitors. The complication is that the bundled price varies meaningfully by dose, and Henry Meds’ marketing emphasizes the lowest tier (“starting at $179”) in a way that doesn’t reflect what most patients pay.

[provider=”henry-meds”]

Real pricing structure: “starting at $179” decoded

Three things to know about Henry Meds pricing in 2026:

• The $179 floor typically maps to compounded liraglutide (a daily injection, weaker and older than semaglutide) or to a 12-month prepay locked at the lowest dose. Most patients on injectable semaglutide pay more.
• Compounded semaglutide rises through the dose ladder: lower starting doses sit near $197/mo, mid-tier doses around $297/mo, and the upper maintenance doses near $397/mo.
• Compounded tirzepatide starts at $199/mo for the entry tier and scales up — Henry Meds publishes per-dose pricing rather than a single flat rate.

Compounded semaglutide: $197-$397/mo by dose tier

Henry Meds’ injectable compounded semaglutide is the product that anchors most patient journeys. It is prepared by 503A compounding pharmacies under patient-specific prescriptions — meaning it is not an FDA-approved finished product like Wegovy or Ozempic. This is the same regulatory category Mochi Health and Remedy Meds operate in. Our deeper explainer on the legal frame is at compounded vs branded semaglutide in 2026.

The FDA removed semaglutide from its shortage list on February 21, 2025, which restricted 503B mass compounding from the bulks list. 503A patient-specific compounding remains legal in 2026 but is under active FDA scrutiny — the agency’s April 30, 2026 proposal would exclude semaglutide, tirzepatide, and liraglutide from the 503B Bulks List entirely, with public comment open through June 29, 2026. Some major labs (ProRx, BPI Labs) have already exited the category. For Henry Meds patients, the practical risk is supply continuity if its pharmacy partners follow.

Oral semaglutide: $99-$149/mo option

Oral compounded semaglutide is Henry Meds’ cheapest GLP-1 option at $99-$149/mo. It tends to be less effective than injectable semaglutide in head-to-head studies of branded products (Rybelsus vs Wegovy), with most randomized trials showing 5-7% body-weight loss for oral semaglutide versus 12-15% for injectable. For cost-constrained patients or needle-averse patients, it’s a real entry point. For people targeting the ~15% loss seen with Wegovy or the ~21% with Zepbound, injectable is the better expected-value path.

Compounded tirzepatide: from $199/mo

Tirzepatide is the molecule in Zepbound and Mounjaro — and the molecule at the center of the Eli Lilly v. Henry Meds litigation. Henry Meds offers compounded tirzepatide starting at $199/mo for the entry dose tier. For comparison, LillyDirect’s Self-Pay Journey Program now sells branded Zepbound vials at $299-$449/mo (the lower end requires refill within 45 days). The compounded-vs-branded delta has narrowed dramatically from where it sat in 2024.

Trustpilot 4.5 across 12,000 — and why Trustpilot flagged it

Henry Meds shows a Trustpilot rating near 4.5 out of 5 stars across roughly 12,000 reviews. On its face, that’s a strong signal. The complication: Trustpilot itself has applied a consumer warning flag to the profile for suspected inauthentic review activity. That doesn’t mean every positive review is fake — many are clearly from real patients describing real outcomes — but it means the aggregate number should be discounted, not taken at face value.

Patterns to look at when reading the reviews yourself: clustering of five-star reviews around specific date windows, generic language that doesn’t reference a real clinical interaction, and the ratio of recent verified buyers versus older reviews. The same caution applies in reverse: many of the one-star reviews are also clearly from real patients describing real billing or shipping problems.

BBB F-rating: 100% non-response to 25 complaints

The Better Business Bureau rates Henry Meds at F — the lowest grade. The driver is structural: the BBB reports a 100% non-response rate to the 25 formal complaints filed against the company. Complaint themes cluster around refund disputes, shipping delays, and difficulty cancelling. The F rating doesn’t say the medication is unsafe — it says the company does not engage with the BBB’s complaint-resolution process.

That is a real, specific reputational signal, separate from the Trustpilot question, and it should weigh in any decision. If you sign up, assume that disputes will need to be resolved through your credit-card issuer rather than through company customer service.

The Eli Lilly v. Henry Meds lawsuit (April 2025) — current status

In April 2025, Eli Lilly filed suit against Henry Meds over its compounded tirzepatide marketing practices. The litigation is part of a broader Lilly campaign targeting compounders following the FDA’s resolution of the tirzepatide shortage. As of May 2026 the case remains active. Lilly’s core claim is that compounded tirzepatide is not equivalent to Zepbound or Mounjaro and that marketing it as such misleads consumers; Henry Meds’ defense centers on its 503A patient-specific framework and clinical-decision context.

For patients, the practical impact is uncertainty rather than immediate disruption — Henry Meds continues to operate and dispense in May 2026. But it is reasonable to factor litigation risk into any 12-month prepay commitment.

What’s actually included: visits, labs, supplies, shipping

The Henry Meds monthly price includes: initial clinician visit, follow-up visits as needed, the compounded or oral medication itself, injection supplies (syringes, alcohol wipes) for injectables, and shipping. Labs are reviewed by the clinical team but generally require you to obtain bloodwork separately (either through your PCP or through a partner lab) before starting injectable GLP-1 therapy. Insurance is not accepted — Henry Meds is cash-pay only, though HSA/FSA cards are typically eligible.

Henry Meds vs Mochi vs Remedy: 3-column comparison

[provider=”mochi”]

See our full best GLP-1 telehealth provider rankings for 2026 for the eight-provider matrix.

Who should consider Henry Meds (and who should not)

Consider Henry Meds if: you want a single-bill bundled price with no separate membership fee, you’ve decided on compounded semaglutide or tirzepatide as your path, and you’re comfortable handling disputes through your card issuer if customer service fails. The lower-dose tiers ($197-$199) are competitive once you factor in the absence of a membership fee.

Avoid Henry Meds if: you want brand-name Wegovy or Zepbound (Henry Meds doesn’t sell branded), you require an insurance-billed pathway, or the combination of an F BBB rating and active Eli Lilly litigation is a deal-breaker. For brand-name routes, see our GLP-1 without insurance guide for LillyDirect and NovoCare cash-pay paths, or Remedy Meds for a compounded competitor without the active lawsuit. Sequence/WW Clinic is the cheapest insurance-route option for those with commercial coverage.

How to cancel and refund policy reality check

Cancellation is handled in-app or via support email. Patients on a 12-month prepay should expect that pro-rated refunds are at the company’s discretion and have historically been a primary complaint driver. The honest read: if you commit to a 12-month prepay to access the $179 floor, treat that commitment as final. Month-to-month billing offers more optionality at higher per-month cost.

Be aware of GLP-1 side effects — nausea, vomiting, and constipation are common in early weeks, and a small share of patients discontinue inside the first 8 weeks for tolerability reasons. A short-commit option preserves the choice to stop.

[provider=”remedy-meds”]

Frequently Asked Questions

Sources

• BBB profile — Henry Meds LLC, Boise ID (verified May 2026)
• Trustpilot — henrymeds.com profile (verified May 2026)
• FDA — Clarifies policies for compounders as national GLP-1 supply begins to stabilize
• LillyDirect — Zepbound Self-Pay Journey pricing (verified May 2026)
• NovoCare — Wegovy/Ozempic self-pay pricing (verified May 2026)

Medical disclaimer: Information here is educational only. GLP-1 medications can cause serious side effects including pancreatitis, gallbladder disease, and thyroid C-cell tumors (boxed warning). Compounded semaglutide and tirzepatide are not FDA-approved as finished products. Consult a licensed clinician before starting, switching, or stopping any prescription weight-loss medication.